Asahi Intecc Co 7747.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 7747.T. It has been listed since 1 July 2004. In the fiscal year to 30 June 2026, it reported revenue of ¥145.42bn and net income of ¥32.08bn. At that date it held total assets of ¥218.28bn and shareholders' equity of ¥173.41bn.

Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical and industrial equipment products. The company is headquartered in Seto-Shi, Aichi-Ken. The company went IPO on 2004-07-01. The firm operates through two business segments. The Medical segment is engaged in the development, manufacture and sale of private label products and OEM products in the medical device field. The Device segment is engaged in the development, manufacture, and sale of components in the medical device field and industrial device field.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Masahiko MiyataChairman of the Board, President of Subsidiary, since 2004¥190.0m
• Mr. Kenji MiyataPresident, Chief Executive Officer, Chairman of Subsidiary, Representative Director, since 2003¥123.0m
• Ms. Mizuho ItoChief Financial Officer, Chief Director of Administration, Manager of Business Strategy Office, Director, since 2016
• Mr. Munechika MatsumotoManaging Director, Chief Director of Basic Technology Research, since 2011
• Mr. Makoto NishiuchiManaging Director, Chief Digital Officer, Chief Senior Director of Medical Business, Manager of Brand Business Unit in Main Medical Business Supervision Unit, since 2015
• Mr. Yuichi IizukaSenior Executive Officer, Manager of Customer Service Strategy Office, Manager of Domestic Sales Group in Brand Business Unit in Main Medical Business Supervision Unit, President of Subsidiary, since 2023
• Mr. Tadakazu KatoSenior Executive Officer, Chief Senior Director of Production, President of Subsidiary, since 2006
• Mr. Yo NobutaSenior Executive Officer, Chief Executive Officer & President of Subsidiaries, since 2023
• Mr. Kazuo ChibaExecutive Officer, President of Subsidiary, since 2023
• Mr. Tomoya EguchiExecutive Officer, Manager of the Regulatory Affairs and Clinical Medicine Unit in Main Medical Business Supervision Unit
• Mr. Tatsuji HigashiExecutive Officer, Manager of Device Business Unit
• Mr. Yasuyuki KawaharaExecutive Officer, Chief Director of Quality Assurance

Overall

70

Environment

75

Social

81

Governance

55

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.